Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Read More Pharma Industry News Pfizer’s Phase 3 clinical trial of XELJANZ in ankylosing spondylitis: A breakthrough in treatment Pfizer has announced the successful completion of a Phase 3 clinical trial for its drug XELJANZ (tofacitinib) in… bypharmanewsdailyNovember 8, 2020
